Omega-3 Market by Type (DHA, EPA, AND ALA), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formula, and Pet Food & Feed), Source (Marine and Plant), and Region - Global Forecast to 2029
[318 Pages Report] According to MarketsandMarkets, the omega-3 market is projected to reach USD 7.4 billion by 2029 from USD 3.9 billion by 2024, at a CAGR of 13.5% during the forecast period in terms of value. Conventional fish oil sources are no longer the sole choice. Sustainable and plant-based substitutes such as algae, flaxseed, and chia seed oil are becoming increasingly popular, addressing dietary limitations and ethical considerations. Furthermore, novel formats like micro-emulsified supplements and fortified food items are enhancing convenience and attractiveness, appealing to a broader demographic. As individuals increasingly adopt proactive approaches to uphold well-being and stave off chronic ailments, Omega-3 supplements and fortified foods emerge as promising solutions, attracting those striving for good health and preemptive care.
To know about the assumptions considered for the study, Request for Free Sample Report
To know about the assumptions considered for the study, download the pdf brochure
Market Dynamics
Driver : Innovative product technologies
Innovative technologies such as encapsulation and flavoring systems play a pivotal role as drivers for the Omega-3 market by masking the natural taste of plant-based Omega-3s, rendering them more palatable and appealing to a broader audience. This is crucial for boosting adoption rates and ensuring compliance with regular consumption. Additionally, the implementation of smart packaging and tracking systems facilitates the monitoring of Omega-3 product quality and potency throughout the supply chain, thereby safeguarding product integrity and offering consumers transparency and confidence. Moreover, advancements in technologies like microencapsulation and phospholipid delivery systems are enhancing the bioavailability of Omega-3s and mitigating unpleasant aftertastes commonly associated with traditional fish oil supplements. These innovations ultimately make Omega-3s more effective and enjoyable, driving market growth.
Restraint : Lower fish oil supply due to sustainability issues among fisheries
The constraint of lower fish oil supply due to sustainability issues among fisheries poses a significant challenge for the Omega-3 market. This limitation stems from the depletion of fish stocks caused by overfishing and unsustainable fishing practices, leading to reduced availability of fish oil, a primary source of Omega-3 fatty acids. As fisheries struggle to maintain sustainable practices, there is a decline in the quantity of fish oil extracted, consequently impacting the production of Omega-3 supplements and fortified foods. This scarcity in the supply chain not only hinders the ability of manufacturers to meet consumer demand but also raises concerns about the long-term viability of sourcing fish oil as a sustainable Omega-3 solution. As a result, the Omega-3 market faces constraints in maintaining adequate supply levels to satisfy market demand, potentially leading to increased prices and reduced accessibility for consumers.
Opportunity : Research for development of alternative sources to obtain omega-3
The research for the development of alternative sources to obtain Omega-3 presents a significant opportunity for the Omega-3 market. This initiative focuses on exploring and harnessing alternative sources such as algae, flaxseed, chia seeds, and marine microorganisms to extract Omega-3 fatty acids. These alternative sources offer several advantages, including sustainability, scalability, and reduced environmental impact compared to traditional fish oil extraction methods. Additionally, advancements in technology and biotechnology have enabled the production of Omega-3 supplements and fortified foods from these alternative sources, ensuring consistent quality and potency. By diversifying the sources of Omega-3 production, the market becomes less reliant on finite marine resources and mitigates the risks associated with overfishing and environmental degradation. Moreover, the availability of plant-based and sustainable Omega-3 options appeals to environmentally conscious consumers and those with dietary restrictions, expanding the consumer base and driving market growth. Therefore, the research for the development of alternative Omega-3 sources presents a promising opportunity to innovate and meet the growing demand for Omega-3 products in a sustainable and responsible manner.
Challenge: Instability of fish oils
The instability of fish oils represents a significant challenge for the Omega-3 market. Fish oils, which are a primary source of Omega-3 fatty acids, are susceptible to oxidation and rancidity due to their high levels of unsaturated fats. This instability can lead to a reduction in product quality, potency, and shelf life, negatively impacting consumer confidence and market acceptance. Additionally, the development of off-flavors and unpleasant odors in fish oil supplements further diminishes their appeal to consumers. Manufacturers face difficulties in maintaining the stability of fish oil-based Omega-3 products throughout the production, storage, and distribution processes. This challenge necessitates the implementation of stringent quality control measures, including the use of antioxidants, specialized packaging, and storage conditions, to minimize oxidation and preserve product integrity. However, despite these efforts, the instability of fish oils remains a persistent challenge for the Omega-3 market, requiring ongoing research and innovation to overcome.
OMEGA-3 Market Ecosystem
Key players within this market consist of reputable and financially robust omega-3 manufacturers. These entities boast extensive industry tenure, offering diversified product portfolios, cutting-edge technologies, and robust global sales and marketing networks. Prominent companies in this market BASF SE (Germany), Cargill, Incorporated. (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group Plc (Ireland), Croda International Plc (UK), Orkla. (Norway), Corbion (Netherlands), GC Rieber (Norway), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), Cooke Aquaculture Inc. (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), AKER BIOMARINE (Norway), and Polaris (France).
Plant source segment is expected to maintain consistent growth in omega-3 market during the forecast period.
Plant-powered Omega-3s are surging, fueled by ethically-conscious consumers seeking sustainable alternatives. Vegan, vegetarian, and allergy-friendly, these innovative options like algae oil and chia seed extracts boast potential unique health benefits and wider accessibility. Affordability and government initiatives promoting sustainable practices add further momentum. While ensuring potency and educating consumers remain key hurdles, the future of Omega-3 looks green, with this segment poised to shape a more responsible and inclusive market landscape.
The DHA segment is expected to hold the largest market share in the type segment of omega-3 market.
Research strongly supports the health benefits of DHA, from its crucial role in brain development to its potential for heart and eye health. Technology advancements have made DHA more accessible through refined extraction and processing methods. This increased accessibility has led to targeted applications, including pregnancy supplements and infant formula, promoting healthy development from early stages. DHA's influence extends to functional foods like dairy products and beverages, providing convenient ways to incorporate it into daily diets. Effective marketing strategies have solidified DHA's position by highlighting its unique benefits. While DHA leads the Omega-3 market, other players like EPA and ALA are also growing, offering diverse benefits and applications. This diversity ensures that the market can cater to various consumer needs, fostering a thriving landscape focused on individual well-being and holistic health.
North America to dominate the omega-3 market during the forecast period.
In North America, the demand for Omega-3 is increasing, particularly in dietary supplement applications, driven by the recognition of Omega-3's benefits health. Omega-3 fatty acids are among the most popular dietary supplements, known for their potential benefits for heart health, brain function, and overall well-being. The demand for omega-3 supplements in North America has been steadily increasing due to rising awareness about their health benefits and the inclusion of omega-3 in various health recommendations.
Key Market Players
The key players in this market include BASF SE (Germany), Cargill, Incorporated. (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group Plc (Ireland), Croda International Plc (UK), Orkla. (Norway), Corbion (Netherlands), GC Rieber (Norway), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), Cooke Aquaculture Inc. (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), AKER BIOMARINE (Norway), and Polaris (France). These market participants are emphasizing the expansion of their footprint via agreements and partnerships. They maintain a robust presence in North America, Asia Pacific, South America, RoW, and Europe, supported by manufacturing facilities and well-established distribution networks spanning across these regions.
Want to explore hidden markets that can drive new revenue in Omega-3 Market?
Scope of the Report
Want to explore hidden markets that can drive new revenue in Omega-3 Market?
Report Metric |
Details |
Market size estimation |
2024–2029 |
Base year considered |
2023 |
Forecast period considered |
2024–2029 |
Units considered |
Value (USD) |
Segments Covered |
By Type, Source, Application, and Region |
Regions covered |
North America, Europe, South America, Asia Pacific, and RoW |
Companies studied |
|
This research report categorizes the omega-3 market based on type, source, application, and region.
Target Audience
- Omega-3 traders, retailers, and distributors
- Omega-3 manufacturers & suppliers
- Related government authorities, commercial research & development (R&D) institutions.
- Regulatory bodies, including government agencies and NGOs.
- Commercial research & development (R&D) institutions and financial institutions.
- Government and research organizations.
- Venture capitalists and investors.
- Technology providers to omega-3 and omega-3 companies.
- Associations and industry bodies.
Omega-3 Market:
By Type
- Docosahexaenoic Acid (DHA)
- Eicosapentaenoic Acid (EPA)
- Alpha-Linolenic Acid (ALA)
By Source
- Marine Source
- Plant Source
By Application
- Dietary Supplements
- Functional Foods & Beverages
- Pharmaceuticals
- Infant Formula
- Pet Food & Feed
By Region:
- North America
- Europe
- Asia Pacific
- South America
- Rest of the World (RoW)
Recent Developments
- In February 2023, GC Rieber VivoMega has introduced VivoMega Algae Oils, a line of high-concentration vegan Omega-3 sourced from microalgae and sourced from the ocean.
- In March 2023, Pelagia has invested USD 40 million in the facility of Epax which is subsidiary of Pelagia in Aalesund. This facility will help the company to implement new technology known as EOP+Tech for EPA & DHA products.
- In November 2021, AlgiSys BioSciences, Inc. Raised funding of USD 45 Million. This funding will fuel the company's initial commercial strategies, which are propelled by increasing global demand for EPA omega-3 fish oil substitutes.
- In September 2023, in a collaborative effort, Aker BioMarine and Swisse introduced a groundbreaking product within Australia's Listed Assessed medicine category. Swisse Ultiboost High Strength Krill Oil, incorporating Aker BioMarine's Superba Boost Krill oil, received approval and is now listed on the Australia Register of Therapeutic Goods (ARTG) under AUST L(A) 417392.
Frequently Asked Questions (FAQ):
Which are the major companies in the omega-3 market? What are their major strategies to strengthen their market presence?
The key players in this include BASF SE (Germany), Cargill, Incorporated. (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group Plc (Ireland), Croda International Plc (UK), Orkla. (Norway), Corbion (Netherlands), GC Rieber (Norway), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), Cooke Aquaculture Inc. (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), AKER BIOMARINE (Norway), and Polaris (France). These players in this market are focusing on increasing their presence through agreements and collaborations. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities along with strong distribution networks across these regions.
What are the drivers and opportunities for the omega-3 market?
Increasing consumer awareness of the health advantages associated with omega-3 fatty acids, particularly in promoting heart health, cognitive function, and overall wellness, is a key factor propelling market growth. With a growing emphasis on health, individuals are actively seeking out omega-3 enriched products such as supplements, functional foods, and fortified beverages. Emerging markets, notably in Asia-Pacific and Latin America, offer promising avenues for expansion in the omega-3 market. Factors such as rising incomes, shifting dietary habits, and heightened health consciousness in these regions are fueling demand for omega-3 fortified goods. Concerns surrounding overfishing and environmental sustainability have spurred a heightened interest in responsibly sourced omega-3 products. Companies that can showcase sustainable sourcing practices and a commitment to environmental preservation stand to gain a competitive edge in this market.
Which region is expected to hold the highest market share?
North America has a large and mature dietary supplements market. Omega-3 supplements, including fish oil capsules and other formulations, are widely consumed by individuals looking to maintain their health and prevent chronic diseases. The popularity of dietary supplements contributes to the growth of the omega-3 market. There's a strong awareness of the health benefits of omega-3 fatty acids among consumers in North America. This awareness has been fueled by extensive marketing efforts, health education campaigns, and widespread availability of information about the benefits of omega-3s in maintaining heart health, reducing inflammation, and supporting brain function.
Which are the key technology trends prevailing in the omega-3 market?
Microencapsulation is a technology that encloses Omega-3 oils within tiny particles, shielding them from degradation and bolstering stability. This process heightens the bioavailability and extends the shelf life of Omega-3 supplements, guaranteeing uniform quality and effectiveness. Similarly, nanotechnology is increasingly employed to enhance the delivery of Omega-3 fatty acids, amplifying their absorption and efficacy. Nano emulsions and nanostructured lipid carriers facilitate the creation of Omega-3 supplements with minute particle dimensions, resulting in enhanced solubility and bioavailability.
What is the total CAGR expected to be recorded for the omega-3 market during 2024-2029?
The CAGR is expected to record as of 13.5% from 2024-2029. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
- 5.1 INTRODUCTION
-
5.2 MACROECONOMIC INDICATORSPREVENTIVE HEALTHCARE EXPENDITUREGROWING GERIATRIC POPULATION
-
5.3 MARKET DYNAMICSDRIVERS- Growing consumer awareness regarding health benefits of omega-3- Increasing use of omega-3 fatty acids in food and feed products- Growing adoption of innovative production technologiesRESTRAINTS- Lower fish oil supply due to sustainability issues among fisheries- Lack of clarity among consumers about daily recommended intake and health claimsOPPORTUNITIES- Increasing research for development of alternative sources to obtain omega-3- Favorable regulatory environment- Application of microencapsulation technology to regulate release of nutrients in fortified food & beveragesCHALLENGES- High costs involved in R&D activities- Highly unstable fish oil prices- Instability of omega-3 oils
- 5.4 INVESTMENT AND FUNDING SCENARIO
- 6.1 INTRODUCTION
-
6.2 VALUE CHAIN ANALYSISRESEARCH & PRODUCT DEVELOPMENTMANUFACTURINGMARKETING & SALESDISTRIBUTIONPOST-SALES SERVICES
-
6.3 TECHNOLOGY ANALYSISMOLECULAR DISTILLATIONALGAE FERMENTATION
-
6.4 PATENT ANALYSISLIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET (2014–2023)
-
6.5 ECOSYSTEM ANALYSISDEMAND SIDESUPPLY SIDE
-
6.6 TRADE ANALYSISEXPORT DATAIMPORT DATA
-
6.7 PRICING ANALYSISAVERAGE SELLING PRICE TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCEAVERAGE SELLING PRICE TREND OF OMEGA-3, BY SOURCEAVERAGE SELLING PRICE TREND OF MARINE SOURCES, BY REGIONAVERAGE SELLING PRICE TREND OF PLANT SOURCES, BY REGION
- 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 6.9 KEY CONFERENCES AND EVENTS, 2024
-
6.10 REGULATORY LANDSCAPEREGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONSREGULATORY LANDSCAPE- North America- Europe- Asia Pacific- South America- RoW
-
6.11 CASE STUDY ANALYSISVERAMARIS ASSISTED BLAIR IN PRODUCING OMEGA-3 FATTY ACIDS FROM NATURAL MARINE ALGAEMIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGYOMEGA-3 SUPPLEMENTS HELPED REDUCE SEIZURE FREQUENCY IN GREAT DANE SUFFERING FROM REFRACTORY CANINE EPILEPSY
-
6.12 PORTER'S FIVE FORCES ANALYSISINTENSITY OF COMPETITIVE RIVALRYBARGAINING POWER OF SUPPLIERSBARGAINING POWER OF BUYERSTHREAT OF SUBSTITUTESTHREAT OF NEW ENTRANTS
-
6.13 KEY STAKEHOLDERS & BUYING CRITERIAKEY STAKEHOLDERS IN BUYING PROCESSBUYING CRITERIA
- 7.1 INTRODUCTION
-
7.2 DOCOSAHEXAENOIC ACIDLOWERED RISK OF ALZHEIMER'S DISEASE TO DRIVE MARKET GROWTH
-
7.3 EICOSAPENTAENOIC ACIDREDUCED SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
-
7.4 ALPHA-LINOLENIC ACIDGROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND
- 8.1 INTRODUCTION
-
8.2 MARINESURGING DEMAND AMONG PREGNANT WOMEN FOR HEALTHY FETAL DEVELOPMENT TO DRIVE MARKET
-
8.3 PLANTGROWING USE OF FLAX SEEDS TO PREVENT CANCER TO BOOST DEMAND
- 9.1 INTRODUCTION
-
9.2 DIETARY SUPPLEMENTGROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIET TO DRIVE MARKET
-
9.3 FUNCTIONAL FOOD & BEVERAGEABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
-
9.4 PHARMACEUTICALGROWING APPLICATION TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
-
9.5 INFANT FORMULARISING CONSUMPTION OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
-
9.6 PET FOOD AND FEEDGREATER EMPHASIS ON BUILDING STRONG IMMUNITY IN PETS TO DRIVE MARKET
- 10.1 INTRODUCTION
-
10.2 NORTH AMERICANORTH AMERICA: RECESSION IMPACTUS- Growing demand for plant-based omega-3 dietary supplements to drive marketCANADA- Increased application in functional food & beverages to boost demandMEXICO- Growing focus on preventing heart diseases to drive market
-
10.3 EUROPEEUROPE: RECESSION IMPACTGERMANY- Less fish consumption to boost demand for omega-3-based supplementsUK- Ability to boost brain function and reduce inflammation to drive marketFRANCE- Ongoing innovations to boost quality and stability of omega-3-rich oils formulation to drive marketNORWAY- Production of genetically modified canola to offer lucrative growth opportunities to playersITALY- High production of dietary supplements, functional food products, and beverages to boost demandSPAIN- Need for sufficient consumption of ALA, DHA and EPA from foods to accelerate demandNETHERLANDS- Growing incidences of depression, autism, and ADHD to drive marketREST OF EUROPE
-
10.4 ASIA PACIFICASIA PACIFIC: RECESSION IMPACTCHINA- Increasing focus on product innovations and diversifications to drive marketINDIA- Growing incidences of heart failure to drive marketJAPAN- Rising use of innovative formulation technology to create opportunities for manufacturers of omega-3 productsAUSTRALIA- Government-led initiatives to increase awareness regarding omega-3 to drive marketNEW ZEALAND- Increasing consumer awareness and government regulations for omega-3 supplements to drive market growthREST OF ASIA PACIFIC
-
10.5 SOUTH AMERICASOUTH AMERICA: RECESSION IMPACTBRAZIL- Rising demand for algal oils to drive marketARGENTINA- Commercialization of omega-3 products to fuel market growthREST OF SOUTH AMERICA
-
10.6 ROWROW: RECESSION IMPACTAFRICA- South Africa- Egypt- Nigeria- Rest of AfricaMIDDLE EAST- Saudi Arabia- UAE- Qatar- Rest of Middle East
- 11.1 OVERVIEW
- 11.2 MARKET SHARE ANALYSIS, 2022
- 11.3 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2020–2024
- 11.4 BRAND/PRODUCT ANALYSIS
- 11.5 SEGMENTAL REVENUE ANALYSIS, 2020–2022
- 11.6 KEY PLAYERS’ ANNUAL REVENUE, 2022 VS. REVENUE GROWTH, 2020–2022
- 11.7 EBIT/EBITDA ANALYSIS, 2022
- 11.8 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022
- 11.9 COMPANY VALUATION AND FINANCIAL METRICS
-
11.10 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2022STARSEMERGING LEADERSPERVASIVE PLAYERSPARTICIPANTSCOMPANY FOOTPRINT: KEY PLAYERS, 2023- Company footprint- Type footprint- Source footprint- Application footprint- Region footprint
-
11.11 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2022PROGRESSIVE COMPANIESRESPONSIVE COMPANIESDYNAMIC COMPANIESSTARTING BLOCKSCOMPETITIVE BENCHMARKING, START-UPS/SMES, 2023- List of key start-ups/SMEs- Competitive benchmarking of key start-ups/SMEs
-
11.12 COMPETITIVE SCENARIOPRODUCT LAUNCHESDEALSEXPANSIONSOTHERS
-
12.1 KEY PLAYERSBASF SE- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewCARGILL, INCORPORATED- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewDSM-FIRMENICH- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewADM- Business overview- Products/Solutions/Services offered- MnM viewKERRY GROUP PLC- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewAKER BIOMARINE- Business overview- Products/Solutions/Services offered- Recent developments- MNM viewCRODA INTERNATIONAL PLC- Business overview- Products/Solutions/Services offered- MnM viewORKLA- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewCORBION- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewPELAGIA AS- Business overview- Products/Solutions/Services offered- Recent developments- MNM viewKD PHARMA GROUP SA- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewGC RIEBER- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewCOOKE AQUACULTURE INC.- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewALGISYS BIOSCIENCES, INC.- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewGOLDEN OMEGA- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewPOLARIS- Business overview- Products/Solutions/Services offered- Recent developments- MnM view
-
12.2 OTHER PLAYERSBTSA- Business overview- Products/Solutions/Services offered- MnM viewFARBEST BRANDS- Business overview- Products/Solutions/Services offered- MnM viewKINOMEGA BIOPHARM INC.- Business overview- Products/Solutions/Services offered- MnM viewPHARMA MARINE AS- Business overview- Products/Solutions/Services offered- MnM viewRIMFROST AS- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewALGARITHMSOLUTEXCELLANA INC.SINOMEGA BIOTECH ENGINEERING CO., LTDALGAECYTES
- 13.1 INTRODUCTION
- 13.2 LIMITATIONS
-
13.3 COLLAGEN MARKETMARKET DEFINITIONMARKET OVERVIEW
-
13.4 ALGAE PRODUCTS MARKETMARKET DEFINITIONMARKET OVERVIEW
- 14.1 DISCUSSION GUIDE
- 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- 14.3 CUSTOMIZATION OPTIONS
- 14.4 RELATED REPORTS
- 14.5 AUTHOR DETAILS
- TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018–2023
- TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2024 VS. 2029
- TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
- TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM)
- TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS
- TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
- TABLE 7 ROLE OF PARTICIPANTS IN ECOSYSTEM
- TABLE 8 EXPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
- TABLE 9 IMPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
- TABLE 10 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE, 2023 (USD/KG)
- TABLE 11 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF OMEGA-3, BY SOURCE, 2019–2023 (USD/KG)
- TABLE 12 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF MARINE SOURCES, BY REGION, 2019–2023 (USD/KG)
- TABLE 13 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PLANT SOURCES, BY REGION, 2019–2023 (USD/KG)
- TABLE 14 OMEGA-3 MARKET: LIST OF CONFERENCES AND EVENTS, 2023–2024
- TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 18 PORTER'S FIVE FORCES ANALYSIS
- TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE (%)
- TABLE 20 KEY BUYING CRITERIA FOR SOURCE SEGMENT
- TABLE 21 OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 22 OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 23 FOOD SOURCES FOR DHA (GRAMS PER SERVING)
- TABLE 24 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 25 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 26 FOOD SOURCES FOR EPA (GRAMS PER SERVING)
- TABLE 27 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 28 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 29 FOOD SOURCES FOR ALA (GRAMS PER SERVING)
- TABLE 30 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 31 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 32 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 33 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 34 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
- TABLE 35 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
- TABLE 36 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
- TABLE 37 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 38 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 39 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
- TABLE 40 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
- TABLE 41 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
- TABLE 42 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
- TABLE 43 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 44 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 45 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
- TABLE 46 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
- TABLE 47 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
- TABLE 48 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
- TABLE 49 OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 50 OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 51 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 52 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 53 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 54 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 55 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 56 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 57 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 58 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 59 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 60 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 61 OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 62 OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 63 OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
- TABLE 64 OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
- TABLE 65 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
- TABLE 66 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 67 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 68 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 69 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 70 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 71 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 72 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 73 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
- TABLE 74 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
- TABLE 75 US: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 76 US: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 77 US: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 78 US: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 79 US: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 80 US: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 81 US: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 82 CANADA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 83 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 84 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 85 CANADA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 86 CANADA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 87 CANADA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 88 CANADA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 89 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 90 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 91 MEXICO: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 92 MEXICO: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 93 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 94 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 95 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
- TABLE 96 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 97 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 98 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 99 EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 100 EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 101 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 102 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 103 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
- TABLE 104 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
- TABLE 105 GERMANY: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 106 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 107 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 108 GERMANY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 109 GERMANY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 110 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 111 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 112 UK: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 113 UK: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 114 UK: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 115 UK: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 116 UK: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 117 UK: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 118 UK: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 119 FRANCE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 120 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 121 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 122 FRANCE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 123 FRANCE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 124 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 125 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 126 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 127 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 128 NORWAY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 129 NORWAY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 130 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 131 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 132 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 133 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 134 ITALY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 135 ITALY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 136 ITALY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 137 ITALY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 138 SPAIN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 139 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 140 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 141 SPAIN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 142 SPAIN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 143 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 144 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 145 NETHERLANDS: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 146 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 147 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 148 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 149 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 150 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 152 REST OF EUROPE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 153 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 154 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
- TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
- TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
- TABLE 169 CHINA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 170 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 171 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 172 CHINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 174 CHINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 176 INDIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 177 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 178 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 179 INDIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 180 INDIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 181 INDIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 182 INDIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 183 JAPAN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 184 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 185 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 186 JAPAN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 188 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 190 AUSTRALIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 191 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 192 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 193 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 194 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 195 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 196 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 197 NEW ZEALAND: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 198 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 199 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 200 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 201 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 202 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 203 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 204 REST OF ASIA PACIFIC: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
- TABLE 205 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 206 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 207 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 208 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 209 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 210 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 211 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
- TABLE 212 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 213 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 214 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 215 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 216 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 217 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 218 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 219 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
- TABLE 220 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
- TABLE 221 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 222 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 223 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 224 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 225 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 226 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 227 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 228 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 229 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 230 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 231 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 232 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 233 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 234 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 235 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 236 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 237 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 238 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 239 ROW: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
- TABLE 240 ROW: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 241 ROW: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 242 ROW: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 243 ROW: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 244 ROW: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 245 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 246 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 247 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
- TABLE 248 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
- TABLE 249 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
- TABLE 250 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 251 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 252 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 253 AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 254 AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 255 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 256 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 257 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 258 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 259 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 260 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 261 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 262 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 263 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 264 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 265 EGYPT: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 266 EGYPT: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 267 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 268 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 269 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 270 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 271 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 272 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 273 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 274 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 275 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 276 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 277 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 278 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 279 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 280 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 281 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
- TABLE 282 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 283 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 284 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 285 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 286 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 287 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 288 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 289 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 290 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 291 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 292 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 293 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 294 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 295 UAE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 296 UAE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 297 UAE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 298 UAE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 299 UAE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 300 UAE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 301 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 302 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 303 QATAR: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 304 QATAR: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 305 QATAR: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 306 QATAR: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 307 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
- TABLE 308 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 309 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
- TABLE 310 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 311 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
- TABLE 312 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
- TABLE 313 OMEGA-3 MARKET: DEGREE OF COMPETITION
- TABLE 314 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, 2020–2024
- TABLE 315 OVERALL COMPANY FOOTPRINT
- TABLE 316 OMEGA-3 MARKET: BY TYPE FOOTPRINT
- TABLE 317 OMEGA-3 MARKET: BY SOURCE FOOTPRINT
- TABLE 318 OMEGA-3 MARKET: BY APPLICATION FOOTPRINT
- TABLE 319 OMEGA-3 MARKET: BY REGION FOOTPRINT
- TABLE 320 OMEGA-3 MARKET: LIST OF KEY START-UPS/SMES
- TABLE 321 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
- TABLE 322 OMEGA-3 MARKET: PRODUCT LAUNCHES, JANUARY 2020– FEBRUARY 2024
- TABLE 323 OMEGA-3 MARKET: DEALS, JANUARY 2020– FEBRUARY 2024
- TABLE 324 OMEGA-3 MARKET: EXPANSIONS, JANUARY 2020– FEBRUARY 2024
- TABLE 325 OMEGA-3 MARKET: OTHERS, JANUARY 2020– FEBRUARY 2024
- TABLE 326 BASF SE: COMPANY OVERVIEW
- TABLE 327 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 328 BASF SE: PRODUCT LAUNCHES
- TABLE 329 CARGILL, INCORPORATED: COMPANY OVERVIEW
- TABLE 330 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 331 CARGILL, INCORPORATED: DEALS
- TABLE 332 DSM-FIRMENICH: COMPANY OVERVIEW
- TABLE 333 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 334 DSM-FIRMENICH: PRODUCT LAUNCHES
- TABLE 335 ADM: COMPANY OVERVIEW
- TABLE 336 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 337 KERRY GROUP PLC: BUSINESS OVERVIEW
- TABLE 338 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 339 KERRY GROUP PLC: DEALS
- TABLE 340 AKER BIOMARINE: COMPANY OVERVIEW
- TABLE 341 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 342 AKER BIOMARINE: PRODUCT LAUNCHES
- TABLE 343 AKER BIOMARINE: DEALS
- TABLE 344 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
- TABLE 345 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 346 ORKLA: COMPANY OVERVIEW
- TABLE 347 ORKLA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 348 ORKLA: DEALS
- TABLE 349 CORBION: COMPANY OVERVIEW
- TABLE 350 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 351 CORBION: PRODUCT LAUNCHES
- TABLE 352 CORBION: EXPANSIONS
- TABLE 353 PELAGIA AS: COMPANY OVERVIEW
- TABLE 354 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 355 PELAGIA AS: DEALS
- TABLE 356 KD PHARMA GROUP SA: COMPANY OVERVIEW
- TABLE 357 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 358 KD PHARMA GROUP SA: EXPANSIONS
- TABLE 359 GC RIEBER: COMPANY OVERVIEW
- TABLE 360 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 361 GC RIEBER: PRODUCT LAUNCHES
- TABLE 362 GC REIBER: DEALS
- TABLE 363 GC RIEBER: EXPANSIONS
- TABLE 364 COOKE AQUACULTURE INC.: COMPANY OVERVIEW
- TABLE 365 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 366 COOKE AQUACULTURE INC.: DEALS
- TABLE 367 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
- TABLE 368 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 369 ALGISYS BIOSCIENCES, INC.: OTHERS
- TABLE 370 GOLDEN OMEGA: COMPANY OVERVIEW
- TABLE 371 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 372 GOLDEN OMEGA: DEALS
- TABLE 373 POLARIS: COMPANY OVERVIEW
- TABLE 374 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 375 POLARIS: PRODUCT LAUNCHES
- TABLE 376 POLARIS: OTHERS
- TABLE 377 BTSA: COMPANY OVERVIEW
- TABLE 378 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 379 FARBEST BRANDS: COMPANY OVERVIEW
- TABLE 380 FARBEST BRANDS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 381 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
- TABLE 382 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 383 PHARMA MARINE AS: COMPANY OVERVIEW
- TABLE 384 PHARMA MARINE AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 385 RIMFROST AS: COMPANY OVERVIEW
- TABLE 386 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 387 RIMFROST AS: DEALS
- TABLE 388 ADJACENT MARKETS
- TABLE 389 COLLAGEN MARKET, BY FORM, 2019–2022 (USD MILLION)
- TABLE 390 COLLAGEN MARKET, BY FORM, 2023–2030 (USD MILLION)
- TABLE 391 ALGAE PRODUCTS MARKET, BY SOURCE, 2018–2022 (USD MILLION)
- TABLE 392 ALGAE PRODUCTS MARKET, BY SOURCE, 2023–2028 (USD MILLION)
- FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN
- FIGURE 2 OMEGA-3 MARKET: DEMAND-SIDE CALCULATION
- FIGURE 3 OMEGA-3 MARKET: SUPPLY-SIDE CALCULATION
- FIGURE 4 OMEGA-3 MARKET: SUPPLY SIDE
- FIGURE 5 DATA TRIANGULATION
- FIGURE 6 INDICATORS OF RECESSION
- FIGURE 7 GLOBAL INFLATION RATE, 2011–2022
- FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION)
- FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON OMEGA-3 MARKET
- FIGURE 10 OMEGA-3 MARKET: EARLIER FORECAST VS. RECESSION FORECAST
- FIGURE 11 OMEGA-3 MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
- FIGURE 12 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 13 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
- FIGURE 14 OMEGA-3 MARKET: REGIONAL SHARE, 2023
- FIGURE 15 RISING CHRONIC DISEASES TO DRIVE MARKET GROWTH
- FIGURE 16 DOCOSAHEXAENOIC ACID SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES OF ASIA PACIFIC MARKET IN 2023
- FIGURE 17 DIETARY SUPPLEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 18 DOCOSAHEXAENOIC ACID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE FROM 2024 TO 2029
- FIGURE 19 MARINE SEGMENT TO CLAIM LARGER MARKET SHARE DURING FORECAST PERIOD
- FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2020
- FIGURE 21 POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2012–2022
- FIGURE 22 MARKET DYNAMICS: OMEGA-3 MARKET
- FIGURE 23 RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
- FIGURE 24 MICROALGAE PROCESSING FOR OMEGA-3
- FIGURE 25 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING
- FIGURE 26 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
- FIGURE 27 KEY PATENTS GRANTED IN OMEGA-3 MARKET, 2014–2024
- FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET, 2014–2024
- FIGURE 29 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS
- FIGURE 30 TRENDS INFLUENCING OMEGA-3 MARKET
- FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE
- FIGURE 32 BUYING CRITERIA
- FIGURE 33 DOCOSAHEXAENOIC ACID SEGMENT TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 34 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
- FIGURE 35 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 36 INDIA TO RECORD FASTEST GROWTH IN GLOBAL OMEGA-3 MARKET
- FIGURE 37 NORTH AMERICA: REGIONAL SNAPSHOT
- FIGURE 38 OMEGA-3 MARKET IN NORTH AMERICA: RECESSION IMPACT ANALYSIS
- FIGURE 39 OMEGA-3 MARKET IN EUROPE: RECESSION IMPACT ANALYSIS
- FIGURE 40 ASIA PACIFIC: REGIONAL SNAPSHOT
- FIGURE 41 OMEGA-3 MARKET IN ASIA PACIFIC: RECESSION IMPACT ANALYSIS
- FIGURE 42 OMEGA-3 MARKET IN SOUTH AMERIC: RECESSION IMPACT ANALYSIS, 2023
- FIGURE 43 OMEGA-3 MARKET IN ROW: RECESSION IMPACT ANALYSIS
- FIGURE 44 BRAND/PRODUCT ANALYSIS FOR KEY BRANDS
- FIGURE 45 THREE-YEAR SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN OMEGA-3 MARKET (USD BILLION)
- FIGURE 46 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH (%), 2020–2022
- FIGURE 47 EBIT/EBITDA (USD BILLION)
- FIGURE 48 GLOBAL SNAPSHOT OF KEY PARTICIPANTS
- FIGURE 49 COMPANY VALUATION OF FEW MAJOR COMPANIES
- FIGURE 50 EV/EBITDA OF KEY COMPANIES
- FIGURE 51 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
- FIGURE 52 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2022
- FIGURE 53 BASF SE: COMPANY SNAPSHOT
- FIGURE 54 CARGILL, INCORPORATED.: COMPANY SNAPSHOT
- FIGURE 55 DSM-FIRMENICH: COMPANY SNAPSHOT
- FIGURE 56 ADM: COMPANY SNAPSHOT
- FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
- FIGURE 58 AKER BIOMARINE: COMPANY SNAPSHOT
- FIGURE 59 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
- FIGURE 60 ORKLA: COMPANY SNAPSHOT
- FIGURE 61 CORBION: COMPANY SNAPSHOT
- FIGURE 62 PELAGIA AS: COMPANY SNAPSHOT
The study involved four major activities in estimating the current size of the omega-3 market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the omega-3 market.
In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles from recognized authors, gold & silver standard websites, directories, and databases were referred to identify and collect information. This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the omega-3 market.
Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.
Primary Research
Extensive primary research was conducted after obtaining information regarding the omega-3 market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and South America. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, research, and development teams, and related key executives from distributors, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, source, application, and region.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the total size of the Omega-3 Market. These approaches were also used extensively to estimate the size of various dependent submarkets. The research methodology used to estimate the market size includes the following:
- Key players were identified through extensive secondary research.
- Primary and secondary research determined the industry’s value chain and market size.
- All percentage share splits and breakdowns were determined using secondary sources and verified through primary sources.
- All the possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
- The following figure provides an illustrative representation of the complete market size estimation process implemented in this research study for an overall estimation of the omega-3 market in a consolidated format.
The following sections (bottom-up & top-down) depict the overall market size estimation process employed for the purpose of this study.
Global Omega-3 Market: Bottom-Up Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Omega-3 Market: Top-Down Approach
Data Triangulation
After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To estimate the overall omega-3 market and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.
Market Definition
According to the US Department of Health & Human Services, “Omega-3 fatty acids (omega-3s) have a carbon-carbon double bond located three carbons from the methyl end of the chain. Omega-3s, sometimes referred to as “n-3s,” are present in certain foods, such as flaxseed and fish, as well as dietary supplements, such as fish oil. Several different omega-3s exist, but the majority of scientific research focuses on three: alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). ALA contains 18 carbon atoms, whereas EPA and DHA are considered “long-chain” (LC) omega-3s because EPA contains 20 carbons, and DHA contains 22. ALA is found mainly in plant oils, such as flaxseed, soybean, and canola oils. DHA and EPA are found in fish and other seafood.”
Key Stakeholders
- Manufacturers, dealers, and suppliers of omega-3
- Government bodies
- API, pharmaceutical products, and fortified food manufacturers
- Fisheries and farms
- Intermediate suppliers, such as retailers, wholesalers, and distributors
- Raw material suppliers
- Technology providers
- Industry associations
-
Regulatory bodies and institutions
- World Health Organization (WHO)
- Code of Federal Regulations (CFR)
- US Food and Drug Administration (FDA)
- Codex Alimentarius Commission (CAC)
- EUROPA
- United States Department of Agriculture (USDA)
- Food Processing Suppliers Association (FPSA)
- Logistic providers & transporters
- Research institutes and organizations
- Consulting companies/consultants in the agricultural and animal farming technology sectors
Report Objectives
Market Intelligence
- Determining and projecting the size of the omega-3 market with respect to type, source, application, and region.
- Identifying the attractive opportunities in the market by determining the largest and fastest-growing segments
- Providing detailed information about the key factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
- Providing the regulatory framework and market entry process related to the omega-3 market.
- Analyzing the micro markets with respect to individual growth trends, prospects, and their contribution to the total market.
Competitive Intelligence
- Identifying and profiling the key players in the omega-3 market
- Providing a comparative analysis of market leaders based on the following:
- Product offerings
- Business strategies
- Strengths and weaknesses
- Key financials
- Understanding the competitive landscape and identifying the major growth strategies players across the country adopt.
- Providing insights on key product innovations and investments in the omega-3 market.
Available Customizations:
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
The following customization options are available for the report:
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolio of each company.
Geographic Analysis
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
- Further breakdown of the Rest of Europe into Belgium, Poland, Sweden, and other EU & non-EU countries
- Further breakdown of the Rest of Asia Pacific into Taiwan, South Korea, Indonesia, Malaysia, Thailand, the Philippines, Bangladesh, Singapore, and Vietnam.
- Further breakdown of the Rest of South America into Chile, Peru, Uruguay, Venezuela, Colombia, and other South American countries
Company Information
- Detailed analyses and profiling of additional market players (up to five)
Growth opportunities and latent adjacency in Omega-3 Market
Our company requires an Omega-3 market forecast till 2026, along with other global market metrics.
I would like to understand more about the potential opportunities for entering the omega-3 market. Is it included in the report?
I am working on omega-3 market and would require data related to its application in infant foods and pet food supplements.